Sage Therapeutics Inc. stock soared more than 70% Thursday to mark its biggest-ever one-day price and percentage gain, after the company reported positive results in a mid-stage trial of a treatment for severe depression that could offer doctors a new mechanism to treat the disease.
Latest posts by Market Watch (see all)
- States that voted for Trump are more likely to have growing credit-card debt - February 24, 2018
- Here’s what Americans earning less than $40,000 and over $100,000 worry about - February 24, 2018
- Weekend Sip: This vodka provided 100,000 free meals last year — in 2018, it plans to give 1 million - February 24, 2018